Tokyo, Aug. 6 (Jiji Press)--A Japanese health ministry panel Wednesday approved a plan to cut the price of Lecanemab, an ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s ...

Amid a cautious outlook, Biogen has presented new data at the Alzheimer’s Association International Conference (AAIC) 2025, demonstrating that investigational Leqembi 360 mg subcutaneous maintenance ...

Subtyping is what made precision medicine in cancer a reality. And for successful drug discovery in all its stages, finding ...

The Gates Foundation committed $2.5 billion through 2030 to support dozens of different approaches for improving women’s ...

Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.

Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...

Portfolio Receipts was $727 million in the second quarter of 2025, an increase of 20% compared to $608 million in the second quarter of 2024, primarily driven by the same Royalty Receipts increases ...

Discover key insights from Supernus Pharmaceuticals' Q2 2025 earnings, including revenue growth, new product launches, the Sage Therapeutics ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...

Patient Capital Management highlights Q2 winners like QXO and Nvidia, while exiting NFE over default risks. See what’s ...